Margaret G. Taylor

Margaret G. Taylor

Auto-generated profile, based on publicly available information

Margaret G. Taylor

Division of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2013 in Cancer Research
Verified
Journal Article
Closed access
PDF file
BLByron H Lee
Byron H Lee
MTMargaret G. Taylor
Margaret G. Taylor
PRPeggy Robinet
Peggy Robinet
JSJonathan D Smith
Jonathan D Smith
JSJessica Schweitzer
Jessica Schweitzer
ATAngela H. Ting
Angela H. Ting
Recent epidemiologic data show that low serum cholesterol level as well as statin use is associated with a decreased risk of developing aggressive or advanced prostate cancer, suggesting a role for cholesterol in aggressive prostate cancer development. Intracellular cholesterol promotes prostate cancer progression as a substrate for de novo androgen synthesis and through regulation of AKT signaling. By conducting next-generation sequencing–based DNA methylome analysis, we have discovered marked hypermethylation at the promoter of the major cellular cholesterol efflux transporter, ABCA1, in LNCaP prostate cancer cells. ABCA1 promoter hypermethylation renders the promoter unresponsive to transactivation and leads to elevated cholesterol levels in LNCaP. ABCA1 promoter hypermethylation is enriched in intermediate- to high-grade prostate cancers and not detectable in benign prostate. Remarkably, ABCA1 downregulation is evident in all prostate cancers examined, and expression levels are inversely correlated with Gleason grade. Our results suggest that cancer-specific ABCA1 hypermethylation and loss of protein expression direct high intracellular cholesterol levels and hence contribute to an environment conducive to tumor progression. Cancer Res; 73(3); 1211–8. ©2012 AACR.

1 March 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MTMargaret G. Taylor
Margaret G. Taylor
TJTorsten Joerger
Torsten Joerger
YLYun Li
Yun Li
MSMichael E. Scheurer
Michael E. Scheurer
MRMichael E. Russo
Michael E. Russo
DPDebra L. Palazzi
Debra L. Palazzi
Penicillin allergy is the most common drug allergy in the world.1-5 Although 5% to 10% of the population is labeled as penicillin allergic,6-9 more than 95% of children with this allergy label are not found to have a type 1 IgE-mediated hypersensitivity after penicillin skin testing or oral challenge.4,10-14 Unconfirmed penicillin allergy labels (PALs), specific designations in the medical record to signify a history of penicillin allergy, can lead to potentially unnecessary receipt of broad spectrum, second-line antibiotics. In the hospital setting, children with unconfirmed PALs have prolonged hospital stays, higher rates of adverse events, and more infections due to Clostridium difficile and vancomycin-resistant Enterococcus compared with children without PALs.15-20 Despite the potential harms associated with unsubstantiated PALs, allergy labels are often left unevaluated in a child’s electronic health record (EHR).21

1 December 2015 in Cell Reports
Verified
Journal Article
Open access
JBJeffrey M. Bhasin
Jeffrey M. Bhasin
BLByron H Lee
Byron H Lee
LMLars Matkin
Lars Matkin
MTMargaret G. Taylor
Margaret G. Taylor
BHBo Hu
Bo Hu
ATAngela H. Ting
Angela H. Ting
A critical need in understanding the biology of prostate cancer is characterizing the molecular differences between indolent and aggressive cases. Because DNA methylation can capture the regulatory state of tumors, we analyzed differential methylation patterns genome-wide among benign prostatic tissue and low-grade and high-grade prostate cancer and found extensive, focal hypermethylation regions unique to high-grade disease. These hypermethylation regions occurred not only in the promoters of genes but also in gene bodies and at intergenic regions that are enriched for DNA-protein binding sites. Integration with existing RNA-sequencing (RNA-seq) and survival data revealed regions where DNA methylation correlates with reduced gene expression associated with poor outcome. Regions specific to aggressive disease are proximal to genes with distinct functions from regions shared by indolent and aggressive disease. Our compendium of methylation changes reveals crucial molecular distinctions between indolent and aggressive prostate cancer.

1 February 2019 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
CFCatherine E. Foster
Catherine E. Foster
MTMargaret Taylor
Margaret Taylor
ESErica K. Schallert
Erica K. Schallert
SRScott Rosenfeld
Scott Rosenfeld
KKKatherine Y. King
Katherine Y. King
Brodie abscess is a subacute hematogenous osteomyelitis characterized by intraosseous abscess formation. Treatment recommendations and clinical outcomes for this unusual infection are not well established. We report 15 cases of Brodie abscess in a 10-year retrospective review of pediatric patients at Texas Children’s Hospital and describe their clinical presentation and outcomes.

20 January 2022 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MTMargaret G. Taylor
Margaret G. Taylor
SNSarah K. Nicholas
Sarah K. Nicholas
LSLisa R. Forbes Satter
Lisa R. Forbes Satter
CMCaridad Martinez
Caridad Martinez
LCLindsay H. Cameron
Lindsay H. Cameron
Background: Infants with inborn errors of immunity (IEI), born in countries where Bacillus-Calmette-Guerin (BCG) vaccination is recommended at birth, are at risk of developing infectious complications following vaccination. A prompt diagnosis of disseminated BCG infection in these infants is essential, as many will require stem cell transplantation (SCT) for the immunologic cure. In patients with IEI, the mortality risk from disseminated mycobacterial infection is high, both before and following SCT. Methods: A 7-month-old Qatari infant with an IEI, homozygous IKBKB gene mutation, was evaluated at our institution for SCT. He had a history of recurrent pneumonias, but pretransplant evaluation revealed negative cultures from bronchoalveolar fluid, blood and urine. At 8 months of age, the infant developed skin nodules of unclear etiology, prompting additional evaluation. Results: Given his profound immunosuppression and receipt of broad-spectrum antimicrobials, plasma metagenomic next-generation sequencing (mNGS) was obtained and identified Mycobacterium tuberculosis complex within 72 hours. A skin biopsy was performed, and antimycobacterial therapy was initiated. Mycobacterium bovis-BCG was confirmed from cultures 3 weeks later. Treatment was complicated by elevated serum liver transaminases and aminoglycoside-associated high-frequency hearing loss. The infant completed 14 months of treatment from engraftment. Evaluation for active BCG infection after SCT was negative. Conclusion: In an infant with a unique IEI, plasma mNGS provided the first diagnosis of disseminated BCG infection. We believe that early initiation of antimycobacterial treatment improved the infant’s clinical outcome. Plasma mNGS testing should be considered as a noninvasive screen for infectious pathogens in children with IEIs before SCT.

14 June 2017 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
MDMeaghan A Delaney
Meaghan A Delaney
YWYing-Wooi Wan
Ying-Wooi Wan
GKGyoung-Eun Kim
Gyoung-Eun Kim
CCChad J. Creighton
Chad J. Creighton
MTMargaret G Taylor
Margaret G Taylor
MAMatthew L. Linley Anderson
Matthew L. Linley Anderson
Context: Despite progesterone’s key role in uterine smooth muscle tumorigenesis, the mechanisms by which it promotes the growth of uterine leiomyomas remain poorly understood. Objective: The aim of this study was to identify novel gene products mediating progesterone’s effects in uterine leiomyomas. Design: Gene expression profiling was used to identify putative progesterone-regulated genes differentially expressed in uterine leiomyomas, which were then studied in vitro. Methods: Gene expression was comprehensively profiled using the Illumina WG Bead Chip (v2.6) and analyzed using a bioinformatic algorithm that integrates known protein-protein interactions. Genomic binding sites for progesterone receptor (PR) were interrogated by chromatin immunoprecipitation (ChIP-qPCR). siRNAs were used to study gene function in primary cell lines. Results: Our analyses identified secreted frizzled-related protein 4 (sFRP4) as a key gene product functionally linked to PR activation whose expression was a) 2.6-fold higher in leiomyomas than myometrium (n=26, p<0.01) and b) 2.5-fold higher during the proliferative phase of the menstrual cycle (n=26, p<0.01). Direct binding between PR and sFRP4 promoter was observed by ChIP-qPCR. Robust overexpression of SFRP4 was also observed in primary cultures derived from leiomyoma. Progesterone preferentially inhibited SFRP4 expression and secretion in leiomyoma cultures in a dose-dependent manner sensitized by estradiol. Knockdown of sFRP4 inhibited proliferation and apoptosis in primary cultures of both myometrium and leiomyoma. Conclusions: Overexpression of sFRP4 is a robust, progesterone-regulated feature of leiomyomas that enhances smooth muscle proliferation. Further work is needed to further decipher how progesterone’s ability to modulate SFRP4 expression contributes to uterine smooth muscle tumorigenesis.